Response to the letter by Prof Jonathan Deeks to the Lancet EClinicalMedicine editor
Հիմնական հեղինակներ: | Leber, W, Lammel, O, Panovska-Griffiths, J, Czypionka, T |
---|---|
Ձևաչափ: | Journal article |
Լեզու: | English |
Հրապարակվել է: |
Elsevier
2021
|
Նմանատիպ նյութեր
-
Corrigendum to ‘Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study.’ [EClinicalMedicine 59 (2023) 101981]
: Yuming Sun, և այլն
Հրապարակվել է: (2023-08-01) -
Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981]
: Vinicius Fontanesi Blum, MD, MSc, և այլն
Հրապարակվել է: (2021-11-01) -
Corrigendum to “Sex differences in HIV treatment outcomes and adherence by exposure groups among adults in Guangdong, China: A retrospective observational cohort study” [EClinicalMedicine 22 (2020) 100351]
: Linghua Li, և այլն
Հրապարակվել է: (2020-12-01) -
Corrigendum to “Treatment-related adverse events associated with HER2-Targeted antibody-drug conjugates in clinical trials: a systematic review and meta-analysis” [EClinicalMedicine 55 (2022) 101795]
: Zhiwen Fu, և այլն
Հրապարակվել է: (2023-04-01) -
Impact of national-scale targeted point-of-care symptomatic lateral flow testing on trends in COVID-19 infections and hospitalisations during the second epidemic wave in Austria
: Reitzinger, S, և այլն
Հրապարակվել է: (2023)